Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Medicinova Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q4 2022
- Shares held
- 5.59M
- −620.9K (−10.0%) vs. Q4 2022
- Total value
- $12.1M
- −$658.3K (−5.2%) vs. Q4 2022
- New holders
- 1
- 5 more added
- Sold out
- 2
- 19 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GWM Advisors LLC | 8 | $17 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 305 | $659 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 339 | $732 | 0.00% | +5+1.5% | Added |
| BNP Paribas Arbitrage, SA | 412 | $890 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 3,476 | $7.51K | 0.00% | −7,052−67.0% | Reduced |
| Point72 Asset Management, L.P. | 7,675 | $16.6K | 0.00% | +7,675 | New |
| Morgan Stanley | 11,646 | $25.2K | 0.00% | −10,874−48.3% | Reduced |
| WealthTrust Axiom LLC | 12,500 | $27.0K | 0.01% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 14,157 | $31.0K | 0.00% | −9,027−38.9% | Reduced |
| Blankinship & Foster, LLC | 15,700 | $33.9K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 16,657 | $36.0K | 0.00% | −2,087−11.1% | Reduced |
| Charles Schwab Investment Management Inc | 17,843 | $38.5K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 19,586 | $42.3K | 0.00% | −21,651−52.5% | Reduced |
| Tower Research Capital LLC (TRC) | 20,529 | $44.0K | 0.00% | −15,629−43.2% | Reduced |
| Price T Rowe Associates Inc | 20,700 | $45.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 22,702 | $49.0K | 0.00% | −28,317−55.5% | Reduced |
| Capricorn Fund Managers Ltd | 25,379 | $54.8K | 0.02% | −41,337−62.0% | Reduced |
| Susquehanna International Group, LLP | 32,180 | $69.5K | 0.00% | −32,176−50.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 43,300 | $93.5K | 0.00% | −1,200−2.7% | Reduced |
| Jane Street Group, LLC | 52,223 | $112.8K | 0.00% | −215,601−80.5% | Reduced |
| Ergoteles LLC | 69,240 | $149.6K | 0.01% | −41,756−37.6% | Reduced |
| Dimensional Fund Advisors LP | 110,036 | $237.7K | 0.00% | +35,031+46.7% | Added |
| Bank of New York Mellon Corp | 120,200 | $259.6K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 134,359 | $290.2K | 0.00% | −42,900−24.2% | Reduced |
| Barclays PLC | 139,100 | $300.5K | 0.00% | −9,300−6.3% | Reduced |
| State Street Corp | 142,298 | $307.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 144,400 | $312.0K | 0.00% | +2,100+1.5% | Added |
| Bridgeway Capital Management, LLC | 145,147 | $313.5K | 0.01% | −50,000−25.6% | Reduced |
| UBS Group AG | 145,232 | $313.7K | 0.00% | −9,242−6.0% | Reduced |
| Northern Trust Corp | 155,742 | $336.4K | 0.00% | −6,485−4.0% | Reduced |
| HRT Financial LP | 163,819 | $353.0K | 0.00% | −15,383−8.6% | Reduced |
| JPMorgan Chase & Co | 176,376 | $381.0K | 0.00% | −72,969−29.3% | Reduced |
| Millennium Management LLC | 251,941 | $544.0K | 0.00% | +315+0.1% | Added |
| Geode Capital Management, LLC | 437,247 | $944.5K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 447,957 | $967.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 625,831 | $1.35M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 714,881 | $1.54M | 0.00% | +3,099+0.4% | Added |
| Essex Woodlands Management, Inc. | 1,105,941 | $2.39M | 1.38% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,674−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,440−100.0% | Sold out |